Stockreport

NeuroVive Pharmaceutical AB Interim Report January - September 2019

ABLIVA AB  (NEVPF) 
NASDAQ:AMEX Investor Relations: neurovive.com/investor
PDF STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - SeptemberNeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT recei [Read more]